(Q36304186)

13 August 2017

1 reference

title

Therapeutic approaches to raising plasma HDL-cholesterol levels (English)

1 reference

13 August 2017

Thompson MM

1

1 reference

13 August 2017

Reed SC

series ordinal

2

1 reference

13 August 2017

Cockerill GW

series ordinal

3

1 reference

13 August 2017

publication date

1 December 2004

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

84-89

1 reference

HDL: the metabolism, function, and therapeutic importance

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High-density lipoprotein--the clinical implications of recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High-density lipoproteins and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

High-density lipoprotein: multipotent effects on cells of the vasculature.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Artificial HDL as an anti-atherosclerotic drug

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0044

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0044

1 reference

13 August 2017

1 reference